Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.17 USD | -6.92% | -10.96% | +28.61% |
03-20 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
03-19 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.61% | 352M | |
+18.56% | 47.02B | |
+48.77% | 41.86B | |
+0.42% | 41.76B | |
-4.27% | 28.8B | |
+11.81% | 26.05B | |
-22.22% | 19.15B | |
+4.37% | 12.55B | |
+29.31% | 12.34B | |
-4.00% | 11.82B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Transcript : Tenaya Therapeutics, Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 08